Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
CellX Biosolutions develops a biological method that uses bacteria to break down PFAS ("forever chemicals"), positioned as an alternative to conventional disposal methods. The company operates in the environmental cleantech and biotech space.
2 investors
Celularity is a regenerative and cellular medicine company developing and commercializing biomaterial products and allogeneic, cryopreserved cell therapies derived from the postpartum placenta to target age-related diseases. It operates its own integrated manufacturing, translational research, and biobanking facility for placenta-derived cellular medicines and advanced biomaterials.
2 investors
Cemvita uses proprietary microbial strains it calls xtremophiles to convert carbon waste into usable resources, applying synthetic biology to heavy industry and biorefining. Its work spans regenerative bio-inputs for agriculture and circular-economy processes for industrial applications.
2 investors
CenExel operates a network of clinical research centers that conduct trials and studies to advance new medical treatments. The company serves pharmaceutical sponsors, biotech firms, and patients by providing clinical research infrastructure and expertise across 18 sites in the United States.
2 investors
Centauri Therapeutics develops the Alphamer platform, a proprietary antibody recruiting molecule technology designed to redirect the immune system against disease targets. The platform is intended for treatment of life-threatening indications across multiple disease areas.
2 investors
Centerline Biomedical develops IOPSยฎ, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
2 investors
Cepheid manufactures molecular diagnostic instruments and tests that automate PCR-based testing for infectious diseases, oncology, and human genetics. The company serves institutions ranging from central laboratories to near-patient settings with automated diagnostic solutions.
2 investors
Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1ฮฒ pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1ฮฒ antibody.
2 investors
Ceretype develops brain imaging and analysis tools that provide insights into brain circuitry for therapeutic development and clinical care of psychiatric and neurological disorders. The company serves the healthcare ecosystem including pharmaceutical companies, clinicians, and research organizations.
2 investors
Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance. It serves pharma and biotech teams developing KRAS-directed cancer therapies for NSCLC, pancreatic (PDAC), and colorectal cancers, providing benchmarking, biomarker, and combination-strategy evidence.
2 investors
Activating the immune system to recognize and destroy tumor cells. (NASDAQ: CMPI) (Acquired by Regeneron)
2 investors
Chemomab is a clinical-stage biotech developing therapies that target the CCL24 cytokine involved in fibro-inflammatory diseases, with its lead antibody nebokitug tested in conditions including primary sclerosing cholangitis, systemic sclerosis, MASH and idiopathic pulmonary fibrosis. The company focuses on anti-fibrotic and anti-inflammatory treatments for patients with fibrotic diseases.
2 investors
Chemtros is a research-focused specialty chemical manufacturer founded in 2006 that produces pharmaceutical intermediates and active pharmaceutical ingredients (APIs), electronic materials, industrial adhesives, and semiconductor materials for various industries. The company leverages accumulated synthesis expertise combined with blending technology to serve customers across pharmaceuticals, electronics, and advanced materials sectors.
2 investors
2 investors
Citizen Health builds a platform that gives patients with rare and complex diseases access to personalized guidance and allows them to share their health data to advance research and treatment development. The company serves patients and families navigating rare conditions, operating in the digital health and rare disease research space.
2 investors
Advancing clinical candidates for cardiovascular, metabolic and kidney diseases. (NASDAQ: CINC) (Acquired by AstraZeneca)
2 investors
CiRC Biosciences develops cellular reprogramming therapies that convert fibroblasts directly into specific neurons and cell types lost in degenerative eye and brain diseases. Its programs target dopaminergic neurons in Parkinson's disease, GABAergic interneurons in refractory epilepsy, and orexin neurons in treatment-resistant narcolepsy, building on prior retinal cell replacement work.
2 investors
Circuit Clinical describes its team culture, employee benefits, and hiring, but the page provides no concrete detail about its products or services.
2 investors
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests. The company serves researchers, clinicians, and biopharma partners with diagnostic tools for conditions like Alzheimer's and Parkinson's.
2 investors
2 investors
Claris Bio develops biologic therapies for sight-threatening eye diseases, with a current focus on bringing CSB-001, a novel treatment for patients with limbal stem cell deficiency, through clinical development and to market.
2 investors
Clean Food Group is a UK-based food tech company that uses fermentation to produce sustainable, function-specific oils and fats as alternatives to traditional ingredients for food, cosmetics, and pet food manufacturers. The company's proprietary CLEAN OilCellโข platform transforms food waste into high-performance ingredients at competitive prices and with reduced environmental impact.
2 investors
Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
2 investors
Ipsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
2 investors